- …
- …
MedicalDevice
In Vitro Standards & Custom Assays
Oroxcell offers alternative in vitro toxicology assays to help understand the safety profile of your medical device and support your dossiers. These will identify and evaluate any existing toxicity and human exposure risks for the final product and individual chemical compounds, mixtures and or extracts.
Since 2004, Oroxcell has been involved for the development and validation of In vitro / In chemico assays that reached scientific and quality criteria to support critical toxicological end points according to existing OECD guidelines, and also to develop and validate novel assays permitting the assessment of novel endpoints or products that cannot accurately be tested using existing guidelines.
In Vitro ADME
In Vitro Absorption
- Oral Absorption
- Cutaneous Absorption
In Vitro Metabolism
- Hepatic Metabolism
- Extra Hepatic Metabolism
In Vitro Distribution
In Vitro Toxicology
Cutaneous Absorption
- Tissue Absorption
- Tissue Distribution
Sensitisation
- DPRA LCMMS OECD 442C
- RHE IL-18
- H-ClaT
Genotoxicity
- Micronucleous OECD
- RHE Micronucleus
- Ames OECD 442C
Phototoxicity
- 3T3 OECD
- RHE Phototoxicity
- Photosensitisation
Sensitisation
- DPRA LCMMS OECD 442C
- RHE IL-18
- H-ClaT
Click on image to enhance product description
Partnership based Developments
Tailor-Made Tests
Efficacy/Pharmacology
Tailor-Made Tests
- Any Request ?
About us
Oroxcell
102 Avenue Gaston Roussel
93230 Romainville
FRANCE
Contact us :
+33 1 41 83 72 20
contact@
© 2019